公式動画ピックアップ

AAPL   ADBE   ADSK   AIG   AMGN   AMZN   BABA   BAC   BL   BOX   C   CHGG   CLDR   COKE   COUP   CRM   CROX   DDOG   DELL   DIS   DOCU   DOMO   ESTC   F   FIVN   GILD   GRUB   GS   GSK   H   HD   HON   HPE   HSBC   IBM   INST   INTC   INTU   IRBT   JCOM   JNJ   JPM   LLY   LMT   M   MA   MCD   MDB   MGM   MMM   MSFT   MSI   NCR   NEM   NEWR   NFLX   NKE   NOW   NTNX   NVDA   NYT   OKTA   ORCL   PD   PG   PLAN   PS   RHT   RNG   SAP   SBUX   SHOP   SMAR   SPLK   SQ   TDOC   TEAM   TSLA   TWOU   TWTR   TXN   UA   UAL   UL   UTX   V   VEEV   VZ   WDAY   WFC   WK   WMT   WORK   YELP   ZEN   ZM   ZS   ZUO  

  公式動画&関連する動画 [アストラゼネカ AZN]  (ランダムに表示)

Immunology R&D: Unlocking the science
astrazeneca   2026-09-21 に公開
  Immune-mediated diseases can vary widely in how they present, progress and respond to treatment across individuals. Every patient is different – even if they have the sam   ...more
Minimal Residual Disease Explained: Understanding MRD in Haematologic Care
astrazeneca   2026-09-03 に公開
  MRD testing can help researchers detect small numbers of cancer cells that may remain even when there are no visible signs of blood cancer. In this video, explore how min   ...more
Immunology R&D: Connecting science to the clinic
astrazeneca   2026-08-13 に公開
  Immune-mediated diseases affect 1 in 10 people. The last two decades have seen advances in treatment, but today too many patients still struggle to manage their symptoms,   ...more
Armouring CAR T-cell therapies
astrazeneca   2026-08-11 に公開
  In solid tumours, the hostile tumour microenvironment (TME) can limit the effectiveness of cell therapies. AstraZeneca is researching armouring technologies that could a   ...more
What does it take to better understand blood cancer?
astrazeneca   2026-06-12 に公開
  In this film Anas Younes highlights the complexity of blood cancers and why a deeper understanding of biology is so important. By bringing together haematology research,   ...more
The potential of T-cell receptor therapies
astrazeneca   2026-05-27 に公開
  Understand the evolving role of T-cell receptor therapies (TCR T) in cancer immunotherapy, as Mark Cobbold and Gavin Bendle discuss AstraZeneca’s approach to this modalit   ...more